Published

Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The International journal on drug policy
Date: 2021-12-01
Source: PubMed
DOI: 10.1016/j.drugpo.2021.103380
PubMed: 34329952

Authors

Yaden DB Berghella AP Regier PS Garcia-Romeu A Johnson MW Hendricks PS

Watch author

Derived topics and classifications

psilocybin Addiction Aging Clinical Trial Review Article Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.Harm reduction journal · 2025-11-25 Psychedelic microdosing benefits and challenges: an empirical codebook.Harm reduction journal · 2019-07-10 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-19 Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel.Harm reduction journal · 2023-08-09 Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.Harm reduction journal · 2017-09-05 Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.Harm reduction journal · 2019-11-28 PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related BurnoutClinicalTrials.gov · 2024-11-12